Abstract
Injection drug use has been a major risk factor for transmission of HIV in the United States since the beginning of the HIV epidemic (Des Jarlais & Semaan, 2008) and is a major risk factor for African Americans. While the proportion of injection drug users (IDUs) among HIV-positive persons has decreased over time, the Centers for Disease Control and Prevention (CDC) reported that, at the end of 2007, IDUs accounted for 23% of existing AIDS cases in the United States (30% if men who have sex with men (MSM) and inject drugs are included) (CDC, 2009). By gender, 35% of overall AIDS cases among women and 20% among men are attributed to drug injection (29% among men if MSM/IDUs are included) (CDC, 2009). African Americans are disproportionately affected by HIV and AIDS – in 2006 African American accounted for approximately 12% of the population and 46% of the persons estimated to be living with HIV (CDC, 2008). When looking at the percent of reported AIDS cases attributed to injection drug use within race and gender, it is much higher among African American men (29%) than among white, non Hispanics men (9%) while the percent of AIDS cases attributed to IDUs is similarly high for African American women (33%) and white women (40%) and also is similar among MSM/IDUs for African American men (8%) and white men (9%) (CDC, 2009). For both African American men and women, IDU is the second leading transmission risk category (CDC, 2009).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Academy for Educational Development. (2009). DEBI – Diffusion of Effective behavioral interventions website. Accessed March 16, 2009 from http://www.effectiveinterventions.org.
Armstrong, G. L. (2007). Injection drug users in the United States, 1979–2002: An aging population. Archives of Internal Medicine, 167, 166–173.
Blankenship, K. M., Smoyer, A. B., Bray, S. J., & Mattocks, K. (2005). Black-White disparities in HIV/AIDS: The role of drug policy and the corrections system. Journal of Health Care for Poor and Underserved, 16(4 Suppl B), 140–156.
Broz, D., & Ouellet, L. J. (2008). Racial and ethnic changes in heroin injection in the United States: Implications for the HIV/AIDS epidemic. Drug and Alcohol Dependence, 94, 221–233.
Centers for Disease Control and Prevention. (2007). Syringe exchange programs – United States, 2005. MMWR. Morbidity and Mortality Weekly Report, 56, 1164–1167.
Centers for Disease Control and Prevention. (2008). HIV prevalence estimates – United States, 2006. MMWR. Morbidity and Mortality Weekly Report, 57, 1073–1076.
Centers for Disease Control and Prevention. (2009). HIV/AIDS Surveillance Report, 2007 (Vol. 19). Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention.
Centers for Disease Control and Prevention. (2010a). Compendium of evidence-based HIV prevention interventions. Atlanta, GA: Centers for Disease Control and Prevention. (July 19, 2010). http://www.cdc.gov/hiv/topics/research/prs/evidence-based-interventions.htm.
Centers for Disease Control and Prevention. (2010b). Provisional procedural guidance for community based organizations. Atlanta, GA: Centers for Disease Control and Prevention. (July 10, 2010). http://www.cdc.gov/hiv/topics/prev_prog/AHP/resources/guidelines/pro_guidance.htm.
Collins, C., Harshbarger, C., Sawyer, R., & Hamdallah, M. (2006). The diffusion of effective behavioral interventions project: Development, implementation, and lessons learned. AIDS Education and Prevention, 18(Suppl A), 5–20.
Copenhaver, M. M., Johnson, B. T., Lee, I.-C., Harman, J. J., Carey, M. P., & SHARP Research Team. (2006). Behavioral HIV risk reduction among people who inject drugs: Meta-analytic evidence of efficacy. Journal of Substance Abuse Treatment, 31, 163–171.
Crepaz, N., Marshall, K. J., Aupont, L. W., Jacobs, E. D., Mizuno, Y., Kay, L. S., et al. (2009). The efficacy of HIV/STI behavioral interventions for African-American females in the United States: A meta-analysis. American Journal of Public Health, 99, 1–10.
Des Jarlais, D. C., & Friedman, S. R. (1996). HIV epidemiology and interventions among injection drug users. International Journal of STDs and AIDS, 7(Suppl 2), 57–61.
Des Jarlais, D. C., & Semaan, S. (2005). Interventions to reduce the sexual risk behaviour of injection drug users. International Journal of Drug Policy, 16S, S58–S66.
Des Jarlais, D. C., & Semaan, S. (2008). HIV prevention for injection drug users: The first 25 years and counting. Psychosomatic Medicine, 70, 606–611.
Donoghoe, M. C., Verster, A., Pervilhac, C., & Williams P. (2008). Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): Towards consensus and improved guidance. International Journal of Drug Policy, 19(Suppl 1) 1, S5–S14.
Eke, A. N., Neumann, M. S., Wilkes, A. L., & Jones, P. L. (2006). Preparing effective behavioral interventions to be used by prevention providers: The role of researchers during HIV prevention research trials. AIDS Education and Prevention, 18(Suppl A), 44–58.
Estrada, A. L. (2005). Health disparities among African-American and Hispanic drug injectors – HIV, AIDS, hepatitis B virus and hepatitis C virus: a review. AIDS, 19(Suppl 3), S47–S52.
Farrell, M., Gowing, L., Marsden, J., Ling, W., & Ali, R. (2005). Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy, 16, 67–75.
Garfein, R. S., Golub, E. T., Greenberg, A. E., Hagan, H., Hanson, D. L., Hudson, S. M., Kapadia, F., Latka, M. H., Ouellet, L. J., Purcell, D. W., Strathdee, S. A., Thiede, H., for the DUIT Study Team. (2007). A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS, 21, 1923–1932.
Gibson, D. R., Flynn, N. R., & Perales, D. (2001). Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS, 15, 1329–1341.
Hershberger, S. L., Wood, M. M., & Fisher, D. G. (2003). A cognitive-behavioral intervention to reduce HIV risk behaviors in crack and injection drug users. AIDS and Behavior, 7, 229–243.
Hogben, M., & Leichliter, J. S. (2008). Social determinants and sexually transmitted disparities. Sexually Transmitted Diseases, 35, S13–S18.
Huo, D., & Ouellet, L. J. (2007). Needle exchange and injection-related risk behaviors in Chicago: A longitudinal study. Journal of Acquired Immune Deficiency Syndromes, 45, 108–114.
Jones, T. S., & Coffin, P. O. (2002). Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal. Journal of the American Pharmaceutical Association, 42(Suppl 2), S6–S9.
Kotranski, L., Semaan, S., Collier, K., Lauby, J., Halbert, J., & Feighan, K. (1998). Effectiveness of an HIV risk reduction counseling intervention for out-of-treatment drug users. AIDS Education and Prevention, 10, 19–33.
Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., & Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis. Lancet, 357, 1397–1401.
Ksobiech, K. (2003). A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Education and Prevention, 15, 257–268.
Latka, M. H., Hagan, H., Kapadia, F., Golub, E. T., Bonner, S., Campbell, J. V., Coady, M., Garfein, R. S., Pu, M., Thomas, D. L., Thiel, T. K., & Strathdee, S. A. (2008). A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. American Journal of Public Health, 98, 853–861.
Latkin, C. A., Sherman, S., & Knowlton, A. (2003). HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Health Psychology, 22, 332–339.
Lyles, C. M., Crepaz, N., Herbst, J. H., Kay, L. S., & HIV/AIDS Prevention Research Synthesis Team. (2006). Evidence-based HIV behavioral prevention from the perspective of CDC’s HIV/AIDS Prevention Research Synthesis Team. AIDS Education and Prevention, 18(Suppl A), 21–31.
Magura, S., Kang, S. Y., & Shapiro, J. L. (1994). Outcomes of intensive AIDS education for male adolescent drug users in jail. Journal of Adolescent Health, 15, 457–463.
Margolin, A., Avants, S. K., Warburton, L. A., Hawkins, K. A., & Shi, J. (2003). A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychology, 22, 223–228.
Mays, V. M., Cochran, S. D., & Barnes, N. W. (2007). Race, race-based discrimination, and health outcomes among African Americans. Annual Review of Psychology, 58, 201–225.
McKleroy, V. S., Galbraith, J. S., Cummings, B., Jones, P., Harshbarger, C., Collins, C., Gelaude, D., Carey, J. W., & the ADAPT Team. Adapting evidence-based behavioral interventions for new settings and target populations. AIDS Education and Prevention, 18(Suppl A), 59–73.
McMahon, R. C., Malow, R. M., Jennings, T. E., & Gomez, C. J. (2001). Effects of a cognitive-behavioral HIV prevention intervention among HIV negative male substance abusers in VA residential treatment. AIDS Education and Prevention, 13, 91–107.
Metzger, D., Navaline, H., & Woody, G. (1998). Drug abuse treatment as AIDS prevention. Public Health Reports, 113(Suppl 1), 97–106.
Mizuno, Y., Purcell, D., Borkowski, T. M., Knight, K., & SUDIS Team. (2003). The life priorities of HIV-seropositive injection drug users: Findings from a community-based sample. AIDS and Behavior, 7, 395–403.
Mizuno, Y., Wilkinson, J. D., Santibanez, S., Dawson Rose, C., Knowlton, A., Handley, K., et al. (2006). Correlates of health care utilization among HIV-seropositive injection drug users. AIDS Care, 18, 417–425.
Needle, R. H., Burrows, D., Friedman, S. R., Dorabjee, J., Touze, G., Badrieva, L., et al. (2005). Effectiveness of community-based outreach in preventing HIV/AIDS among injection drug users. International Journal of Drug Policy, 16S, S45–S57.
Prendergast, M. L., Urada, D., & Podus, D. J. (2001). Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. Journal of Consulting and Clinical Psychology, 69, 389–405.
Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992). In search of how people change. American Psychologist, 47, 1101–1113.
Purcell, D. W., Latka, M. H., Metsch, L. R., Latkin, C. A., Gomez, C. A., Mizuno, Y., et al. (2007). Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. Journal of Acquired Immune Deficiency Syndromes, 46(Suppl 2), S35–S47.
Purcell, D. W., Metsch, L., Latka, M., Santibanez, S., Eldred, L., Gomez, C. A., et al. (2004). Behavioral prevention trial with HIV-seropositive injection drug users: Rationale and methods of the INSPIRE Study. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S110–S118.
Rich, J. D., Hogan, J. W., Wolf, F., DeLong, A., Zaller, N. D., Mehrotra, M., & Reinhert, S. (2007). Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug and Alcohol Dependence, 89, 292–297.
Semaan, S., Des Jarlais, D. C., Sogolow, E., Johnson, W. D., Hedges, L. V., Ramirez, G., et al. (2002). A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. Journal of Acquired Immune Deficiency Syndromes, 30, S73–S93.
Sterk, C. E., Theall, K. P., Elifson, K. W., & Kidder, D. (2003). HIV risk reduction among African American women who inject drugs: A randomized controlled trial. AIDS and Behavior, 7, 73–86.
Stratford, D., Mizuno, Y., Williams, K., Courtenay-Quirk, C., & O’Leary, A. (2008). Addressing poverty as a risk for disease: Recommendations from the CDC’s consultation on microenterprise as HIV prevention. Public Health Reports, 123, 9–20.
Strathdee, S. A., & Sherman, S. G. (2003). The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health, 2003(80), 7–14.
The CDC AIDS Community Demonstration Projects Research Group. (1999). Community-level HIV intervention in 5 cities: Final outcome data from the CDC AIDS community demonstration projects. American Journal of Public Health, 89, 336–345.
Watters, J. K., Bluthenthal, R. N., & Kral, A. H. (1995). HIV seroprevalence in injection drug users. Journal of the American Medical Association, 273, 1178.
Wechsberg, W. M., Lam, W. K., Zule, W. A., & Bobashev, G. (2004). Efficacy of a woman focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. American Journal of Public Health, 94, 1165–1173.
Weinhardt, L., Carey, M., Johnson, B., & Bickham, N. (1999). Effects of HIV counseling and testing on sexual risk behavior: A meta-analytic review of published research, 1985–1997. American Journal of Public Health, 89, 1397–1404.
Weissman, G., & Brown, V. (1995). Drug using women and HIV risk reduction and prevention issues. In A. O’Leary & L. S. Jemmott (Eds.), Women at risk: Issues in the primary prevention of AIDS (pp. 175–193). New York: Plenum.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Purcell, D.W., Mizuno, Y., Lyles, C.M. (2010). HIV Prevention Interventions for African American Injection Drug Users. In: McCree, D.H., Jones, K.T., O'Leary, A. (eds) African Americans and HIV/AIDS. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78321-5_13
Download citation
DOI: https://doi.org/10.1007/978-0-387-78321-5_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78320-8
Online ISBN: 978-0-387-78321-5
eBook Packages: MedicineMedicine (R0)